SenzaGen AB (SENZA)

Currency in SEK
5.58
-0.36(-6.06%)
Closed·
Unusual trading volume
Earnings results expected tomorrow
SENZA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.585.84
52 wk Range
3.866.84
Key Statistics
Prev. Close
5.94
Open
5.84
Day's Range
5.58-5.84
52 wk Range
3.86-6.84
Volume
43.84K
Average Volume (3m)
18.67K
1-Year Change
-11.4286%
Book Value / Share
2.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SENZA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

SenzaGen AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

SenzaGen AB Company Profile

SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices. In addition, the company offers regulatory toxicity testing services, including skin corrosion, skin irritation, skin sensitization, and skin absorption; and eye irritation, phototoxicity, and genotoxicity testing services. Further, it provides advisory services, such as pharma, medical devices, cosmetics, and chemical. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden.

SenzaGen AB Earnings Call Summary for Q3/2025

  • Sensagen reported Q3 2025 revenue of 15.2M SEK, an 18% YoY growth, achieving EBITDA break-even, though stock fell 7.69% in pre-market trading
  • ToxHub sales tripled to represent 9% of group sales, while the company expanded its customer base with 10 new Guard customers
  • Despite strong 66% gross margin and 29.3M SEK cash position, market reaction was negative, with stock trading near its 52-week low
  • CEO Peter Nahlstedt highlighted Sensagen's evolution 'from industry challenger to established player' in animal-free testing
  • Forward guidance focuses on scaling business efficiency, investing in medical devices and Aura platform, with potential OECD method approval by 2027
Last Updated: 2025-11-05, 04:52 a/m
Read Full Transcript

Compare SENZA to Peers and Sector

Metrics to compare
SENZA
Peers
Sector
Relationship
P/E Ratio
−11.2x−3.0x−0.5x
PEG Ratio
−0.520.790.00
Price/Book
2.4x2.6x2.6x
Price / LTM Sales
3.1x2.6x3.3x
Upside (Analyst Target)
133.0%72.1%47.1%
Fair Value Upside
Unlock−4.3%5.8%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
15.25M / 17.50M
EPS Revisions
Last 90 days

SENZA Income Statement

FAQ

What Is the SenzaGen (SENZA) Stock Price Today?

The SenzaGen stock price today is 5.58

What Stock Exchange Does SenzaGen Trade On?

SenzaGen is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for SenzaGen?

The stock symbol for SenzaGen is "SENZA."

What Is the SenzaGen Market Cap?

As of today, SenzaGen market cap is 181.39M.

What Is SenzaGen's Earnings Per Share (TTM)?

The SenzaGen EPS (TTM) is -0.55.

When Is the Next SenzaGen Earnings Date?

SenzaGen will release its next earnings report on Feb 16, 2026.

From a Technical Analysis Perspective, Is SENZA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has SenzaGen Stock Split?

SenzaGen has split 1 times.

How Many Employees Does SenzaGen Have?

SenzaGen has 37 employees.

What is the current trading status of SenzaGen (SENZA)?

As of Feb 15, 2026, SenzaGen (SENZA) is trading at a price of 5.58, with a previous close of 5.94. The stock has fluctuated within a day range of 5.58 to 5.84, while its 52-week range spans from 3.86 to 6.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.